検索結果 - Pascal Morel

  • 検索結果 1 - 2 結果 / 2
結果の絞り込み
  1. 1
    Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD

    Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD 著者: Margaux Costes-Albrespic, Natalia Alencar de Pinho, Islam Amine Larabi, Carolla El Chamieh, Solène M. Laville, Denis Fouque, Maurice Laville, Luc Frimat, Jean-Claude Alvarez, Ziad A. Massy, Sophie Liabeuf, Natalia Alencar De Pinho, Dorothée Cannet, Christian Combe, Denis Fouque, Luc Frimat, Aghilès Hamroun, Yves-Edouard Herpe, Christian Jacquelinet, Maurice Laville, Sophie Liabeuf, Ziad A. Massy, Pascal Morel, Christophe Pascal, Roberto Pecoits-Filho, Joost Schanstra, Bénédicte Stengel, Céline Lange, Oriane Lambert, Marie Metzger

    出版事項 2025-07-01

    Introduction: Furosemide is commonly prescribed to patients with chronic kidney disease (CKD) but may impair the kidney’s excretion of protein-bound uremic toxins (PBUTs) via the organic anion transporters 1 and 3 (OAT1 and OAT3). We evaluated the association between furosemide prescription (status...

    詳細記述

    全文の入手
    論文

    お気に入りに追加
    保存先:
  2. 2
    Association of Phenylacetylglutamine and Cognitive Impairment in CKD

    Association of Phenylacetylglutamine and Cognitive Impairment in CKD 著者: Hélène Levassort, Julie Boucquemont, Sophie Liabeuf, Solène M. Laville, Céline Lange, Luc Frimat, Christian Combe, Denis Fouque, Maurice Laville, Christian Jacquelinet, Yves-Edouard Herpe, Islam Amine Larabi, Jean-Claude Alvarez, Natalia Alencar de Pinho, Marion Pépin, Ziad A. Massy, Natalia Alencar de Pinho, Dorothée Cannet, Christian Combe, Denis Fouque, Luc Frimat, Aghilès Hamroun, Yves-Edouard Herpe, Christian Jacquelinet, Maurice Laville, Sophie Liabeuf, Ziad A. Massy, Pascal Morel, Christophe Pascal, Roberto Pecoits-Filho, Joost Schanstra, Bénédicte Stengel, Céline Lange, Oriane Lambert, Marie Metzger

    出版事項 2025-08-01

    Introduction: Chronic kidney disease (CKD) leads to the accumulation of uremic toxins (UTs). Studies have suggested that UTs are associated with cognitive impairment (CI) in patients with CKD. Recently, studies reported that phenylacetylglutamine (PAG) contributes to the association between CKD and...

    詳細記述

    全文の入手
    論文

    お気に入りに追加
    保存先:

検索ツール: